Associated Genetic Biomarkers
Associated Diseases
Associated Pathways


Gene Location [1]
Receptor tyrosine kinase/growth factor signaling
Variant Type

ERBB2 Amplification is present in 2.84% of AACR GENIE cases, with breast carcinoma, esophageal cancer, colorectal adenocarcinoma, non-small cell lung carcinoma, and uterine corpus neoplasm having the greatest prevalence [4].

Top Disease Cases with ERBB2 Amplification

Biomarker-Directed Therapies

Significance of ERBB2 Amplification in Diseases

Breast Carcinoma +

Adenocarcinoma Of The Gastroesophageal Junction +

Gastric Carcinoma +

Malignant Esophageal Neoplasm +

Malignant Solid Tumor +

Gastric Adenocarcinoma +

Non-Small Cell Lung Carcinoma +

Colorectal Carcinoma +

Esophageal Carcinoma +

Endometrial Carcinoma +

Urothelial Carcinoma +

Head And Neck Squamous Cell Carcinoma +

Esophageal Adenocarcinoma +

Ductal Carcinoma In Situ +

Pancreatic Carcinoma +

Melanoma +

Non-Hodgkin Lymphoma +

Ovarian Carcinoma +

Inflammatory Breast Carcinoma +

Prostate Carcinoma +

Cancer +

Lymphoma +

Multiple Myeloma +

Breast Adenocarcinoma +

Malignant Salivary Gland Neoplasm +

Bile Duct Carcinoma +

Colorectal Adenocarcinoma +

Squamous Cell Lung Carcinoma +

Glioblastoma +

Hepatocellular Carcinoma +

Leukemia +

Renal Cell Carcinoma +

Salivary Duct Carcinoma +

Salivary Carcinoma, NOS +

Breast Invasive Ductal Carcinoma +

Salivary Gland Adenocarcinoma +

Digestive System Carcinoma +

Gallbladder Carcinoma +

Bladder Carcinoma +

Esophageal Squamous Cell Carcinoma +

Carcinoma +

Ampulla Of Vater Carcinoma +

Cervical Carcinoma +

Cholangiocarcinoma +

Laryngeal Squamous Cell Carcinoma +

Oral Cavity Squamous Cell Carcinoma +

Oropharyngeal Squamous Cell Carcinoma +

Lung Carcinoma +

Glioma +

Small Cell Lung Carcinoma +

Sarcoma +

B-Cell Non-Hodgkin Lymphoma +

Biliary Tract Neoplasm +

Brain Metastasis +

Central Nervous System Neoplasm +

Ependymoma +

Gastric Squamous Cell Carcinoma +

Gastrointestinal Stromal Tumor +

Germ Cell Tumor +

Hepatobiliary Neoplasm +

Histiocytic And Dendritic Cell Neoplasm +

Hypopharyngeal Squamous Cell Carcinoma +

Lip And Oral Cavity Carcinoma +

Malignant Bone Marrow Neoplasm +

Malignant Glioma +

Malignant Laryngeal Neoplasm +

Medulloblastoma +

Nasal Cavity And Paranasal Sinus Carcinoma +

Nasopharyngeal Carcinoma +

Oropharyngeal Carcinoma +

Peritoneal Mesothelioma +

Salivary Gland Acinic Cell Carcinoma +

Salivary Gland Carcinoma Ex Pleomorphic Adenoma +

Salivary Gland Mucoepidermoid Carcinoma +

Salivary Gland Small Cell Carcinoma +

Salivary Gland Squamous Cell Carcinoma +

Small Intestinal Carcinoma +

Thymic Carcinoma +

Thyroid Gland Carcinoma +


1. Hart R and Prlic A. Universal Transcript Archive Repository. Version uta_20170629. San Francisco CA: Github;2015.

2. The UniProt Consortium. UniProt: a worldwide hub of protein knowledge. Nucleic Acids Research. 2019;47:D506-D515.

3. Liu X, Wu C, Li C, and Boerwinkle E. dbNSFP v3.0: A one-stop database of functional predictions and annotations for human nonsynonymous and splice site SNVs. Human Mutation. 2015;37:235-241.

Liu X, Jian X, and Boerwinkle E. dbNSFP: A lightweight database of human nonsynonymous SNPs and their functional predictions. Human Mutation. 2011;32:894-899.

4. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 4. This dataset does not represent the totality of the genetic landscape; see paper for more information.

5. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.